Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CL(pro)): IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS

Documenti analoghi

• Chimeric Exchange of Coronavirus nsp5 Proteases (3CLpro) Identifies Common and Divergent Regulatory Determinants of Protease Activity
  di: Stobart, Christopher C., et al.
  Pubblicazione: (2013)
• Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4—The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS)
  di: St. John, Sarah E., et al.
  Pubblicazione: (2015)
• X-ray structure and inhibition of the feline infectious peritonitis virus 3C-like protease: Structural implications for drug design
  di: St. John, Sarah E., et al.
  Pubblicazione: (2015)
• Computational modeling of the bat HKU4 coronavirus 3CL(pro) inhibitors as a tool for the development of antivirals against the emerging Middle East respiratory syndrome (MERS) coronavirus
  di: Abuhammad, Areej, et al.
  Pubblicazione: (2017)
• In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors
  di: Gurung, Arun Bahadur
  Pubblicazione: (2020)